|[December 05, 2013]
Novian Health Awarded New Patent for Breast Cancer Treatment Technology
CHICAGO --(Business Wire)--
Health, developer of Novilase®
Breast Therapy, announced the company has received a Notice of
Allowance for a new patent. The U.S. patent, Application No. 12/778,580,
laser therapy in combination with interstitial brachytherapy
treatment. The technology could make breast cancer treatment more
efficient and also reduce treatment time.
The newly issued patent comes as Novian Health is conducting
multi-center studies of its Novilase Interstitial Laser Therapy (ILT)
System for the treatmentof breast cancer. The company is currently
enrolling patients in the U.S., United Kingdom and France.
"The new patent covers technology that has the potential to simplify and
improve therapy for breast cancer patients," said Henry "Chip"
Appelbaum, President and CEO of Novian Health. "This achievement further
validates Novilase technology -- and buttresses our already strong
portfolio of intellectual property covering the monitoring and control
of tumor ablation."
Novian developed the Novilase ILT System for the ablation of small (up
to 20 mm) malignant breast tumors. The company has previously received
FDA 510(k) clearance for the treatment of breast fibroadenomas
and currently offers Novilase at breast centers around the country that
are participating in its ABLATE registry and in the Breast Cancer trial
Novilase is a laser-based device for destroying tumors. This minimally
invasive alternative to conventional surgery provides a safe tumor
treatment alternative while preserving the patient's options for
additional procedures or adjunctive therapies. This image-guided
outpatient procedure does not require general anesthetic or a hospital
stay. Multiple tumors can be treated during a single visit. Therapy
outcomes may be assessed using a variety of currently available imaging
technologies and other methods. Therapy consists of physician placement
of two small gauge needles into the tumor site after local anesthetic,
followed by initiation of the computer-controlled Novilase system.
Treatment times vary from 15-30 minutes.
About Novian Health
Novian Health Inc., located in Chicago, is a privately held medical
device company with proprietary technology for the treatment of tumors
using Interstitial Laser Therapy (ILT). Developed as an alternative to
surgery, the company's technology uses parametrically controlled heating
for the ablation of tumors. Image-guided treatment of breast tumors is
the first application of the technology, and Novilase also has the
potential to treat tumors elsewhere in the body.
For more information, call (312) 266-7200 or access www.novianhealth.com.
[ Back To Technology News's Homepage ]